Jordi Mata-Fink
Directeur Général chez Gate Bioscience, Inc.
Postes actifs de Jordi Mata-Fink
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Analyste en capital-investissement | 01/01/2013 | - |
Gate Bioscience, Inc.
 Gate Bioscience, Inc. BiotechnologyHealth Technology Gate Bioscience, Inc. develops a small molecule modality to treat biology's intractable diseases. The private company is located in the US. | Directeur Général | 01/01/2021 | - |
| Fondateur | 01/01/2021 | - |
Historique de carrière de Jordi Mata-Fink
Anciens postes connus de Jordi Mata-Fink
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Cygnal Therapeutics, Inc.
 Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Fondateur | 01/01/2017 | - |
| RUBIUS THERAPEUTICS | Directeur Technique/Scientifique/R&D | 01/01/2014 | - |
| Fondateur | 01/01/2014 | - |
Formation de Jordi Mata-Fink
| Stanford University | Graduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Founder | 3 |
| Private Equity Analyst | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Finance | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
Cygnal Therapeutics, Inc.
Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Health Technology |
Gate Bioscience, Inc.
Gate Bioscience, Inc. BiotechnologyHealth Technology Gate Bioscience, Inc. develops a small molecule modality to treat biology's intractable diseases. The private company is located in the US. | Health Technology |
- Bourse
- Insiders
- Jordi Mata-Fink
- Expérience
